Póvoa Helvécio Cardoso Corrêa, Chianca Gabriela Ceccon, Iorio Natalia Lopes Pontes Póvoa
Department of Basic Science, Universidade Federal Fluminense, Nova Friburgo, Rio de Janeiro, Brazil.
Infect Dis Ther. 2020 Sep;9(3):417-420. doi: 10.1007/s40121-020-00306-5. Epub 2020 May 30.
This manuscript aims to highlight the risk of Ventilator-Associated Bacterial Pneumonia (VAP) in COVID-19 inpatients. The co-infection has the potential to worsen clinical condition and increase mortality in these patients, as well as to prolong and increase the costs of hospitalization. Preventing, identifying and treating early VAP can increase the chances of successful treatment in patients with COVID-19.
本手稿旨在强调新型冠状病毒肺炎(COVID-19)住院患者发生呼吸机相关性细菌性肺炎(VAP)的风险。这种合并感染有可能使这些患者的临床状况恶化并增加死亡率,还会延长住院时间并增加住院费用。预防、识别和早期治疗VAP可增加COVID-19患者成功治疗的机会。